CEB-01 by Cebiotex for Leiomyosarcoma: Likelihood of Approval

CEB-01 is under clinical development by Cebiotex and currently in Phase I for Leiomyosarcoma.

Health care execs mostly donate to Democrats, but avoid Trump and Harris

A vast majority of CEOs of major health systems and insurers are steering clear of donating their money to either Vice President Harris or former

November 1, 2024

Novel tool uncovers new cell types in the visual system of flies

New York University researchers have discovered new cell types in the visual system of flies, made possible by their creation of a tool that finds

August 1, 2023

Mydecine Provides Q4 2023 Business Update | Psychedelic Invest

Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to

October 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.